Figure 1
Approximately 65% of pancreatic adenocarcinomas are located within the head, 15% in the body and 10% in the tail. The remaining 10% are multifocal or diffuse. Tumors of the head often manifest earlier due to obstructive jaundice (with the characteristic “double duct sign”, as illustrated in our example). In contrast, tumors of the body and tail tend to be diagnosed at later stages and they are associated with a worse prognosis.
Figure 2
Vascular assessment to define resectability status at diagnosis.